Correlation Between GlaxoSmithKline PLC and Avantor

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Avantor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Avantor into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Avantor, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Avantor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Avantor. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Avantor.

Diversification Opportunities for GlaxoSmithKline PLC and Avantor

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between GlaxoSmithKline and Avantor is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Avantor in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avantor and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Avantor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avantor has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Avantor go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Avantor

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Avantor. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 1.39 times less risky than Avantor. The stock trades about -0.03 of its potential returns per unit of risk. The Avantor is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  2,368  in Avantor on November 3, 2024 and sell it today you would lose (140.00) from holding Avantor or give up 5.91% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Avantor

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, GlaxoSmithKline PLC is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.
Avantor 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Avantor has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Avantor is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

GlaxoSmithKline PLC and Avantor Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Avantor

The main advantage of trading using opposite GlaxoSmithKline PLC and Avantor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Avantor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avantor will offset losses from the drop in Avantor's long position.
The idea behind GlaxoSmithKline PLC ADR and Avantor pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Fundamental Analysis
View fundamental data based on most recent published financial statements
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine